Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

BIA

- PMLiVE

NHS England to Vertex: come clean on Orkambi offer

Vertex has offered Orkambi at an almost 90% discount to the NHS, according to BioCentury

- PMLiVE

‘Common Rulebook’ Brexit plans include medicines – but face backlash

Government compromises could be opposed from both sides

- PMLiVE

Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’

CEO writes open letter to prime minister

- PMLiVE

New ABPI president pledges closer collaboration with NHS

UK pharma body appoints a president and vice president for the first time

- PMLiVE

Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again

Public row about confidential pricing talks drags on

- PMLiVE

ABPI’s Aileen Thompson is crowned Healthcare Communiquétor 2018

And 90TEN’s Jenny Squibbs wins Young Achiever at this year’s Communiqué Awards

- PMLiVE

ABPI blames doctor payment disclosure dip on GDPR

Figures drop to 49% from almost 65% last year

EU flag

UK pharma cheers EU science announcement

UK won't be excluded from Horizon research collaboration

The NHS and ABPI at 70: inching closer to the triple win

The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...

- PMLiVE

Pharma and biotech leaders back ’no deal’ Brexit warning

Ongoing division in Conservative party means 'no deal' remains a possibility

- PMLiVE

NHS England’s Simon Stevens – no Trump drug price rhetoric here

Health service supremo will play major role in UK pricing talks

- PMLiVE

ABPI explores the future of medicines

Predicts inhalable nanobots and 3D printed medicine patches

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links